Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02019030 · ClinicalTrials.gov registry record
Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
A clinical trial, sponsored by Olympus Corporation of the Americas.
- Terminated
- Registry status
- 5
- Enrollment target
NCT02019030: Clinical Trial study, sponsored by Olympus Corporation of the Americas.
NCT02019030 is a clinical trial that was terminated before completion, run by Olympus Corporation of the Americas. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02019030 was terminated before completion, sponsored by Olympus Corporation of the Americas.
- TERMINATED
- Registry status
- 5 participants
- Enrollment target
Study Summary
The purpose of this observational study is to evaluate the outcomes of using the PlasmaButton electrode in the treatment on Benign Prostatic Hyperplasia (BPH) while on anticoagulation medication.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-01-03 |
Why NCT02019030 stopped before completion
NCT02019030 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02019030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02019030 about?
NCT02019030 is a clinical study titled "Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode". The purpose of this observational study is to evaluate the outcomes of using the PlasmaButton electrode in the treatment on Benign Prostatic Hyperplasia (BPH) while on anticoagulation medication.
What is the current status of trial NCT02019030?
This trial is currently terminated. The enrollment target is 5 participants. The study started on 2013-12. Estimated completion is 2017-01-03.
Who is sponsoring clinical trial NCT02019030?
This trial is sponsored by Olympus Corporation of the Americas, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia